Legend: drug field target field enzyme field
| Version | 2.5 |
| Creation Date | 2007-08-29 14:53:57 |
| Update Date | 2009-02-19 16:03:48 |
| Primary Accession Number | DB01581 |
| Secondary Accession Number | Not Available |
| Name | Sulfamerazine |
| Drug Type |
|
| Description | A sulfanilamide that is used as an antibacterial agent. [PubChem] |
| Synonyms | Not Available |
| Brand Names | Not Available |
| Brand Mixtures | Not Available |
| Chemical IUPAC Name | 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide |
| Chemical Formula | C11H12N4O2S |
| Chemical Structure | |
| CAS Registry Number | 127-79-7 |
| InChI Identifier | InChI=1/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)/f/h15H |
| InChI Key | QPPBRPIAZZHUNT-YAQRNVERCL |
| KEGG Drug | Not Available |
| KEGG Compound | Not Available |
| PubChem Compound | 5325 ![]() |
| PubChem Substance | 10321119 ![]() |
| ChEBI ID | Not Available |
| PharmGKB ID | PA451541 ![]() |
| HET ID | Not Available |
| GenBank ID | Not Available |
| Drug ID Number [DIN] | Not Available |
| RxList Link | Not Available |
| PDRhealth Link | Not Available |
| Wikipedia Link | http://en.wikipedia.org/wiki/Sulfamerazine ![]() |
| FDA Label | Not Available |
| Material Safety Data Sheet (MSDS) | |
| Synthesis Reference | Not Available |
| Average Molecular Weight | 264.3040 |
| Monoisotopic Molecular Weight | 264.0681 |
| State | Solid |
| Melting Point | 236 oC |
| Experimental Water Solubility | 0.202 mg/mL at 20 oC [YALKOWSKY,SH & DANNENFELSER,RM (1992)] Source: PhysProp |
| Predicted Water Solubility | 3.04e-01 mg/mL Calculated using ALOGPS |
| Experimental LogP/Hydrophobicity | 0.14 [HANSCH,C ET AL. (1995)] Source: PhysProp |
| Predicted LogP | 0.44 Calculated using ALOGPS |
| Experimental LogS | Not Available |
| Predicted LogS | -2.94 Calculated using ALOGPS |
| Experimental Caco2 Permeability | Not Available |
| pKa/Isoelectric Point | Not Available |
| Mass Spectrum | Not Available |
| MOL File | Show | Download ![]() |
| SDF File | Show | Download ![]() |
| PDB File | Show | Download ![]() |
| 2D Structure | |
| 3D Structure | |
| Experimental PDB ID | Not Available |
| Isomeric SMILES | CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1 |
| Canonical SMILES | CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1 |
| Drug Category |
|
| ATC Codes | |
| AHFS Codes | Not Available |
| Indication | Not Available |
| Pharmacology | Not Available |
| Mechanism of Action | Not Available |
| Absorption | Not Available |
| Toxicity | Not Available |
| Protein Binding | Not Available |
| Biotransformation | Not Available |
| Half Life | Not Available |
| Dosage Forms | Not Available |
| Patient Information | Not Available |
| Contraindications | Not Available |
| Interactions | Not Available |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Pathways | Not Available |
| General References | |
| Organisms Affected | Not Available |
This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.